comprehensive -WSS

comprehensive

author：leisure time 2025-10-01 17:20:39 - browse：774

A hospital bed is seen in a COVID-19 unit at Providence Holy Cross Medical Center in the Mission Hills section of Los Angeles, Nov. 19, 2020. Roughly 84 million people are covered by Medicaid, the government-sponsored program that's grown by 20 million people since January 2020, just before the coronavirus pandemic hit. Now, as states begin checking everyone’s eligibility for Medicaid for the first time in three years, as many as 14 million people could lose access to that coverage. – politics and policy coverage from STAT — Jae C. Hong/AP

Roughly 7.7% of Americans didn’t have any health insurance as of this past March — a “record low” uninsured rate, according to the latest health insurance survey from the Centers for Disease Control and Prevention.

However, that uninsured rate — which still translated to more than 25 million Americans with no health coverage — is almost certainly higher now. That’s because the data don’t include the millions of low-income Americans who have lost the Medicaid coverage they gained during the pandemic.

Congress passed a law in March 2020 that gave states extra federal Medicaid funds, but states could only receive that money if they agreed to loosen eligibility requirements and keep more people enrolled. Changes in income or unfiled paperwork were no longer valid reasons to remove someone from Medicaid while the public health emergency was in effect.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Hollywood unions extend contract negotiations for actors

WSS

Antibiotic resistance and the global rise in human conflict

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Antibiotic resistance and the global rise in human conflict

Anesthesiologist group: stop taking Ozempic before surgery

J&J to buy cancer drug developer Ambrx Biopharma

explore

comprehensive

knowledge

BioMarin wins approval for gene therapy to treat hemophilia A

Morgan Health, with ambitious aims, wants you to know it’s still here

In age of alternative facts, a scholarly course on calling out crap

Goldman Sachs launches $650M fund for life science investments

Jerome Adams on the need for new antivirals for Covid

Antibiotic resistance and the global rise in human conflict

Supreme Court strikes down use of affirmative action

Burning questions for the 2024 JPM Healthcare Conference

At least 13 dead in Texas as scorching temps continue

New weight loss drugs work. But how can they best be used?

entertainment

After affirmative action ruling, medical educators look to 'holistic review'

Walensky prepares to leave CDC — and Congress — behind

United colonoscopy coverage change 'may cost lives,' doctors say

Apple is now the first public company to be valued at $3 trillion

Duchenne breakthrough therapy leaves behind pioneering families

UCB departs biotech trade group BIO

focus

Wikipedia

focus

focus